Tag: Sucrose intolerance

Congenital Sucrase-Isomaltase Deficiency (CSID) is a rare genetic disorder affecting an estimated 1 in 5,000 people of European descent [1.10.2]. For those diagnosed, a key question arises: **Is there an alternative to Sucraid?**

Affecting as many as 5 in 100 people in the native communities of Canada, Alaska, and Greenland, Congenital Sucrase-Isomaltase Deficiency (CSID) requires effective management. For those prescribed Sucraid, a key question is: **how long does it take for Sucraid to work?** Most patients report improvement in digestive symptoms within the first two weeks of starting therapy.

Congenital Sucrase-Isomaltase Deficiency (CSID) is a rare genetic disorder affecting as many as 5 in 100 people in the native communities of Greenland, Alaska, and Canada. For those diagnosed, a key question is, **what is the generic name for Sucraid?** The answer is **sacrosidase**.

Congenital Sucrase-Isomaltase Deficiency (CSID) is a rare genetic disorder with a prevalence in people of European descent estimated to be as high as 1 in 500 to 1 in 2,000. For those diagnosed, the question 'Does Sucraid really work?' is critical. This article examines the evidence.